VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
HRZN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
HRZNHorizon Technology Finance Corporation
$3.22$161M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. HRZN
  4. Financial Ratios

Horizon Technology Finance Corporation (HRZN) Financial Ratios

Latest Ratios: P/E Ratio -15.6x · EV/EBITDA N/A · ROE -0.8%. (2009–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

HRZN Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$155M$273M$325M$408M$287M$319M$232M$174M$130M$129M$122M
Enterprise Value$522M$641M$722M$823M$700M$538M$398M$320M$244M$217M$180M
P/E Ratio →-15.63———13.4911.4536.788.929.9613.52—
P/S Ratio3.2837.84192.40—10.779.5822.478.188.7017.86—
P/B Ratio0.410.860.971.260.901.301.090.950.970.960.87
P/FCF1.014.828.198.14———9.93——2.32
P/OCF2.734.828.198.14———9.93——2.32

P/E links to full P/E history page with 30-year chart

HRZN EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—88.76428.11—26.2916.1838.5715.0216.3729.94—
EV / EBITDA—611.90——29.8418.3952.4016.2117.9416.5210.24
EV / EBIT————32.0319.1060.5016.2112.5714.66205.03
EV / FCF—11.3118.2216.44———18.22——3.44

HRZN Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%86.8%124.1%
Operating Margin-22.1%-22.1%-246.4%159.0%82.1%84.7%63.7%92.7%87.5%170.3%-222.8%
Net Profit Margin-36.9%-36.9%-333.9%174.1%79.4%83.5%61.6%91.5%87.3%132.5%64.3%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE-0.8%-0.8%-1.7%-5.3%7.5%12.1%3.2%12.3%9.7%7.0%-3.3%
ROA-0.3%-0.3%-0.7%-2.2%3.3%6.0%1.7%6.4%5.2%4.1%-1.9%
ROIC-0.2%-0.2%-0.4%-1.5%2.6%4.7%1.3%5.0%4.0%4.0%5.0%
ROCE-0.2%-0.2%-0.5%-2.0%3.5%6.3%1.8%6.6%6.6%9.0%11.4%

HRZN Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity1.491.491.391.431.361.050.870.830.940.700.69
Debt / EBITDA451.79451.79——18.508.8024.447.709.337.175.44
Net Debt / Equity—1.151.181.281.300.890.780.790.850.650.42
Net Debt / EBITDA351.01351.01——17.627.5021.877.388.406.673.33
Debt / FCF—6.4910.038.30———8.29——1.12
Interest Coverage-0.05-0.05-0.13-0.541.142.340.682.373.052.860.15

HRZN Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio1.241.245.083.922.594.142.921.662.940.110.43
Quick Ratio1.241.245.083.922.594.142.921.662.940.110.43
Cash Ratio1.111.113.962.891.443.462.230.822.230.070.37
Asset Turnover—0.010.00-0.010.030.060.030.060.060.03-0.03
Inventory Turnover———————————
Days Sales Outstanding———————————

HRZN Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield40.6%19.4%14.3%9.9%10.4%7.7%9.2%8.9%10.5%10.6%12.9%
Payout Ratio————141.1%88.4%334.9%—105.1%142.3%—

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield————7.4%8.7%2.7%11.2%10.0%7.4%—
FCF Yield99.1%20.7%12.2%12.3%———10.1%——43.0%
Buyback Yield0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.4%
Total Shareholder Yield40.6%19.4%14.3%9.9%10.4%7.7%9.2%8.9%10.5%10.6%13.3%
Shares Outstanding—$42M$36M$31M$25M$20M$18M$13M$12M$12M$12M

Key Metrics

Growth RegimeMixed
ProfitabilityWeak
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Warrant marks eroding tangible book value

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Deep Discount to Tangible Book

At 0.53x price-to-tangible book, HRZN trades near TPVG's 0.51x and far below HTGC's 1.46x, implying investors price its venture-debt book as a commodity balance sheet rather than a differentiated asset-management franchise, per recent market pricing data.

The $4.02 share price sits roughly 37% below the $6.43 tangible book value per share reported for 2026Q2, a discount that appears to reflect the ten-quarter pattern of negative or erratic reported earnings rather than any disclosed credit event. A TTM P/E of negative 64.0 against a forward P/E of 5.95 suggests the market is discounting current losses as transitory, but that optimism rests on warrant marks normalizing — an outcome that warrants further investigation given the portfolio's demonstrated volatility. The 31.2% listed dividend yield may be read by some as deep value, though it could equally signal a market-implied expectation of a distribution cut.

Volatility Obscures Lending Spread Economics

ROE swung from 10.2% in 2025Q3 to negative 9.9% in 2026Q2, while NIM held a narrow 1.5-2.2% band, indicating that reported profitability is driven by non-interest income swings rather than core spread performance, as reported in HRZN's financial statements.

Decomposing DuPont, the near-stable NIM of 2.0% in 2026Q2 and an equity-to-assets ratio of 0.50 imply underlying ROA of roughly 1.0% on a spread-only basis, yet the reported ROA of negative 4.6% reveals that warrant and equity marks, not lending economics, dominate the outcome. The unusually thick 50% equity cushion actually dampens ROE mechanically — leverage of only about 2x means each dollar of mark-to-market loss hits a large equity base with minimal offset. For analysts, this suggests HRZN's earnings quality should be assessed through NII and fee-normalized ROE rather than headline returns, which have been negative in five of the last ten quarters.

Efficiency Ratio Rendered Inoperable

The efficiency ratio printed 2.1% in 2026Q2 and 25.1% in 2026Q1, with several quarters showing no meaningful calculation, indicating that negative non-interest income renders the standard cost-control metric analytically useless for this business model.

NIM has compressed modestly from 2.2% in 2024Q1 to 2.0% in 2026Q2, a drift that appears consistent with rising funding costs on a venture-lending book, though the company's 1.5% trough in 2025Q4 suggests the pressure is cyclical rather than structural. The fee income line, printed at negative 31.3% of revenue in 2026Q2 versus positive 41.6% in 2025Q3, means total revenue itself has been negative in multiple periods, making any efficiency calculation arithmetically incoherent. Investors should monitor NIM on a standalone basis and disregard the efficiency ratio entirely until fee income stabilizes.

Overcapitalized Cushion Signals Under-Deployment

Equity reached $417.5M against $832.0M of total assets in 2026Q2, lifting equity-to-assets to 0.50 from 0.39 a year earlier, a cushion far thicker than typical BDC peers that may indicate capacity for capital return rather than balance-sheet strain.

This leverage profile is the inverse of most business development companies — peers such as TPVG and PFLT carry debt-to-equity ratios of 1.33 and 1.65 respectively, while HRZN's implied leverage sits near 2x assets-to-equity. The interpretation is two-sided: the buffer provides genuine protection against the venture-portfolio marks that have driven repeated losses, but it also depresses ROE structurally and suggests the balance sheet is not being deployed at franchise-economics efficiency. Given that dividends accelerated 142% over ten quarters to $25.2M in 2026Q2 alongside a $37.3M net loss, the cushion's sufficiency relative to distribution policy is a metric investors should monitor closely.

Priced With Weakest Peer, Not Best-in-Class

HRZN's 0.53x P/B and negative TTM earnings place it alongside TPVG at the bottom of the peer set, while HTGC commands 1.46x on 17.2% ROE, suggesting the valuation gap reflects earnings consistency rather than asset-class differences within venture lending.

The peer table shows a clean relationship between ROE stability and multiple: HTGC's 17.2% ROE supports a premium multiple, whereas HRZN's ROE, negative in five of ten quarters, appears to cap valuation near the 0.5x tangible book floor shared by lower-returning peers. Notably, even TPVG's 11.0% ROE does not translate into a premium multiple, implying the market applies a structural venture-asset discount across the group, within which HRZN's mark-to-market volatility adds a company-specific penalty. Whether this discount is cyclical — tied to the current venture funding winter — or structural remains the central question for any re-rating thesis.

P/E Misleads on Negative-Number Banks

The most misapplied ratio for HRZN is P/E — a TTM figure of negative 64.0 and a forward figure of 5.95 describe entirely different companies, obscuring the fact that warrant marks, not lending operations, drive the reported loss.

For an asset-heavy lender whose equity-linked marks swing between positive 41.6% and negative 39.8% of revenue across ten quarters, earnings-based multiples are essentially uninterpretable; the same criticism applies to the 27.89x P/S, which is inflated by a near-zero or negative revenue denominator in loss quarters. Investors should instead anchor on price to tangible book value adjusted for normalized warrant marks, or on a NII-based return on equity that isolates the venture-lending spread. The related risk this obscures is that tangible book itself has declined from $9.89 to $6.43 per share over the period, meaning a constant or falling P/B multiple can coincide with genuine economic value erosion, not merely market pessimism.

Download Financial Ratios Data

Includes 30+ ratios · 17 years · Updated daily

Consensus & Technical Research Suite
Open HRZN Terminal

HRZN Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

HRZN — Frequently Asked Questions

Quick answers to the most common questions about buying HRZN stock.

What is Horizon Technology Finance Corporation's P/E ratio?

Horizon Technology Finance Corporation's current P/E ratio is -15.6x. The historical average is 17.8x.

What is Horizon Technology Finance Corporation's ROE?

Horizon Technology Finance Corporation's return on equity (ROE) is -0.8%. The historical average is 5.6%.

Is HRZN stock overvalued?

Based on historical data, Horizon Technology Finance Corporation is trading at a P/E of -15.6x. Compare with industry peers and growth rates for a complete picture.

What is Horizon Technology Finance Corporation's dividend yield?

Horizon Technology Finance Corporation's current dividend yield is 40.57%.

What are Horizon Technology Finance Corporation's profit margins?

Horizon Technology Finance Corporation has 100.0% gross margin and -22.1% operating margin.

How much debt does Horizon Technology Finance Corporation have?

Horizon Technology Finance Corporation's Debt/EBITDA ratio is 451.8x, indicating high leverage. A ratio above 4x may signal elevated financial risk.